Emergent BioSolutions | EBS - 贷款资金

股票价格
9.50
每天变化
0.37 4.05%
每月一次
12.43%
每年
68.14%
Q2 预测
8.94


金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 476.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


贷款资金 更改 日
Acadia Pharmaceuticals USD 0 0 2025-03
Akebia Therapeutics USD 36.39M 11.85M 2026-03
ALKERMES USD 1.48B 1.2B 2026-03
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
ANI Pharmaceuticals USD 286M 5.84M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Coherus Biosciences USD 51.08M 496K 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck USD 46.67B 77M 2026-03
Moderna USD 603M 7M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Sanofi EUR 13.84B 1.88B 2026-03
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Xoma USD 94.38M 7.82M 2025-09